Bronchiolitis Obliterans Syndrome Epidemiology Forecast to 2030

Bronchiolitis Obliterans Syndrome Epidemiology Forecast to 2030

“Delveinsight Business Research”
DelveInsight’s ‘Bronchiolitis Obliterans Syndrome Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Bronchiolitis Obliterans Syndrome epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Bronchiolitis obliterans syndrome (BOS) is a form of chronic lung allograft dysfunction that affects a majority of lung transplant recipients and is the primary factor limiting long-term transplant survival. It is characterized by progressive airflow obstruction resulting in acute rejection of the graft, followed by infections, or other coexistent condition. 

Several risk factors can lead to the development of bronchiolitis obliterans such as exposure to inhaled toxins and gases, including sulfur mustard gas, nitrogen oxides, diacetyl, fly ash, and fiberglass. It is also known to occur after a respiratory viral infection (adenovirus, respiratory syncytial virus), especially in case of children.

According to the American Thoracic Society, Bronchiolitis Obliterans Syndrome (BOS) is a lung condition that can occur after lung transplantation and is the most common form of chronic lung transplant rejection. Up to half of lung transplant recipients develop BOS within 5 years of transplantation.

The DelveInsight Bronchiolitis Obliterans Syndrome epidemiology report gives a thorough understanding of the Bronchiolitis Obliterans Syndrome by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. 

It also provides treatment algorithms and treatment guidelines for Bronchiolitis Obliterans Syndrome in the US, Europe, and Japan. The report covers the detailed information of the Bronchiolitis Obliterans Syndrome epidemiology scenario in seven major countries (US, EU5, and Japan).

 

Key Highlights Of The Report

  • Delveinsight estimated that the total prevalent population of Bronchiolitis Obliterans Syndrome (BOS) in the seven major markets was 16,418, in 2017.

  • Delveinsight observed a total of 6,601 prevalent cases of Bronchiolitis Obliterans Syndrome (BOS) in the United States in 2017 during the study period, 2017– 2030.

  • As per Delveinsight’s analysis, gender-specific diagnosed prevalent cases of Bronchiolitis Obliterans Syndrome (BOS) in the United States were found to be 3,631 males and 2,971 females, in 2017

  • According to DelveInsight’s analysis, males are affected more as compared to females, in case of Bronchiolitis Obliterans Syndrome (BOS).

Bronchiolitis Obliterans Syndrome epidemiology
Request for Sample Pages: 

https://delveinsight.com/sample-request/bronchiolitis-obliterans-syndrome-epidemiology-forecast

Bronchiolitis Obliterans Syndrome Epidemiology

Delveinsight’s Bronchiolitis Obliterans Syndrome epidemiology division provides insights about historical and current patient pool and forecasted trends for every seven major countries. 

The Bronchiolitis Obliterans Syndrome epidemiology data are studied through all possible divisions to give a better understanding of the Disease scenario in 7MM. 

The Bronchiolitis Obliterans Syndrome epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. 

It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

 

Scope of the Report

  • The report provides insight into the historical and forecasted patient pool of Bronchiolitis Obliterans Syndrome in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan.

  • The report assesses the disease risk and burden and highlights the unmet needs of Bronchiolitis Obliterans Syndrome.

  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.

  • The Bronchiolitis Obliterans Syndrome report provides a detailed overview explaining Bronchiolitis Obliterans Syndrome causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns.

  • The Bronchiolitis Obliterans Syndrome Epidemiology Report and Model provide an overview of the risk factors and global trends of Bronchiolitis Obliterans Syndrome in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan).

  • The report provides the segmentation of the Bronchiolitis Obliterans Syndrome epidemiology. 

 

Key Questions Covered In The Bronchiolitis Obliterans Syndrome Report Include:

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Bronchiolitis Obliterans Syndrome?

  • What are the key findings pertaining to the Bronchiolitis Obliterans Syndrome epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?

  • What would be the total number of patients of Bronchiolitis Obliterans Syndrome across the 7MM during the forecast period (2017-2030)?

  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?

  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?

  • What is the disease risk, burden and unmet needs of the Bronchiolitis Obliterans Syndrome?

  • What are the currently available treatments of Bronchiolitis Obliterans Syndrome?

 

Key Benefit of Bronchiolitis Obliterans Syndrome Epidemiology Report 

  • The Bronchiolitis Obliterans Syndrome Epidemiology report will allow the user to –

  • Develop business strategies by understanding the trends shaping and driving the global Bronchiolitis Obliterans Syndrome market

  • Quantify patient populations in the global Bronchiolitis Obliterans Syndrome market to improve product design, pricing, and launch plans

  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Bronchiolitis Obliterans Syndrome therapeutics in each of the markets covered

  • Understand the magnitude of Bronchiolitis Obliterans Syndrome population by its epidemiology

  • The Bronchiolitis Obliterans Syndrome Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

 

Table of Contents

  1. Key Insights 

  2. Executive Summary of Bronchiolitis Obliterans Syndrome

  3. Bronchiolitis Obliterans Syndrome Disease Background and Overview

  • Bronchiolitis Obliterans Syndrome Sign and Symptoms

  • Bronchiolitis Obliterans Syndrome Pathophysiology

  • Bronchiolitis Obliterans Syndrome Risk Factors

  • Bronchiolitis Obliterans Syndrome Diagnosis

  1. Bronchiolitis Obliterans Syndrome Patient Journey

  2. Bronchiolitis Obliterans Syndrome Epidemiology and Patient Population

  3. Bronchiolitis Obliterans Syndrome Treatment Algorithm, Current Treatment, and Medical Practices

  4. KOL Views on Bronchiolitis Obliterans Syndrome 

  5. Bronchiolitis Obliterans Syndrome Unmet Needs

  6. Appendix

  7. DelveInsight Capabilities

  8. Disclaimer

*The table of contents is not exhaustive; will be provided in the final report

About  DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

 

Related Reports:

Bronchiolitis Obliterans Syndrome Market Insight, Epidemiology and Market Forecast 2030

DelveInsight’ s Bronchiolitis Obliterans Syndrome Market Insights, Epidemiology and Market Forecast 2030 report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology.

 

Bronchiolitis Obliterans Syndrome Pipeline Insights, 2020

Bronchiolitis Obliterans Syndrome Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Bronchiolitis Obliterans Syndrome market.

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/